Tag Archives: Joseph France

Acadia Healthcare (ACHC) Receives a Hold from Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph France maintained a Hold rating on Acadia Healthcare (ACHC – Research Report) today and set a price target of $39. The company’s shares closed yesterday at $32.05. France observed: “We rate ACHC Neutral primarily to reflect

Cantor Fitzgerald Remains a Hold on Acadia Healthcare (ACHC)

In a report released today, Joseph France from Cantor Fitzgerald maintained a Hold rating on Acadia Healthcare (ACHC – Research Report), with a price target of $39. The company’s shares opened today at $37.61. France noted: “We rate ACHC Neutral

Cantor Fitzgerald Believes Global Medical REIT (NYSE: GMRE) Won’t Stop Here

Cantor Fitzgerald analyst Joseph France reiterated a Buy rating on Global Medical REIT (GMRE – Research Report) today and set a price target of $11. The company’s shares opened today at $9.47, close to its 52-week high of $10.05. France

National Health Investors (NHI) Receives a Hold from Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph France reiterated a Hold rating on National Health Investors (NHI – Research Report) today and set a price target of $80. The company’s shares opened today at $75.21. France observed: “. We are lowering our 2019

Cantor Fitzgerald Keeps Their Buy Rating on Genesis Healthcare (GEN)

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on Genesis Healthcare (GEN – Research Report) today and set a price target of $7. The company’s shares opened today at $1.68. France noted: “We rate GEN $7 price target. We

AAC Holdings (AAC) Receives a Buy from Cantor Fitzgerald

In a report released today, Joseph France from Cantor Fitzgerald maintained a Buy rating on AAC Holdings (AAC – Research Report), with a price target of $14. The company’s shares closed yesterday at $5.31, close to its 52-week low of